A Quality Improvement Project: Decreasing the Time from Diagnosis to Surgery in Patients with Bladder Cancer
|
|
- Rosa Peters
- 5 years ago
- Views:
Transcription
1 Decreasing the Time from Diagnosis to Surgery in Patients with Bladder Cancer Abstract Otto Sandoval, M.D. 1 Andrew Blake 2 Josh Barnes- Livermore 3 Doug Salvador, M.D., MPH 4 Brian Jumper, M.D. 5 Jennifer Powers 6 Moritz Hansen, M.D. 7 Craig Hawkins, M.D. 8 Background: A delay of greater than 90 days from diagnosis of muscle- invasive bladder cancer to radical cystectomy is associated with increased pathologic stage and decreased cause- specific survival. Seventy consecutive surgical candidate patients with T2 muscle- invasive transitional cell carcinoma of the bladder underwent radical cystectomy between 2004 and 2009 at Maine Medical Center in Portland, Maine. Thirty- four eligible patients had preoperative T2 muscle- invasive bladder cancer and did not receive neoadjuvant chemotherapy. Eight patients (24%) had delay greater than 90 days between diagnosis and cystectomy. Objective: To identify the factors delaying the time between diagnosis of muscle- invasive bladder cancer to cystectomy and develop interventions to achieve 100% of surgeries within 90 days of diagnosis. 1 Urology Resident, Maine Medical Center 2 Oncology Systems Coordinator, Maine Medical Center Cancer Institute 3 Urology Program Manager, Maine Medical Center 4 Vice President, Quality and Patient Safety, Maine Medical Center; Assistant Professor of Medicine, Tufts University School of Medicine 5 Director of Pediatric Urology, Maine Medical Partners Urology; Assistant Clinical Professor, Tufts University School of Medicine 6 Oncology Nurse Navigator, Maine Medical Center Cancer Institute 7 Co- Director, Division of Urology, Maine Medical Partners Urology; Assistant Clinical Professor, Tufts University School of Medicine 8 Maine Medical Partners Urology, Assistant Clinical Professor 1
2 Design: Quality improvement, retrospective case series. Setting: One community / university- associated tertiary care and teaching institution with a multi- state referral base, in the MaineHealth System. Intervention: Analysis using Clinical Microsystems methodology examining causes of delay and proposed alterations in care pathway to overcome them. Main outcome measures: The percentage of patients exceeding 90- day interval between diagnosis and surgery. Results: Six problem categories were identified, with 26 possible points of intervention recognized. The points of intervention were prioritized in terms of the impact and projected efficacy of intervention. The major contributors included scheduling, patient choice factors, and comorbidity evaluation. Preliminary results after implementation in 2011 indicate construction of a system that allows for 100% of the patients with T2 disease to undergo radical cystectomy within 90 days of diagnosis. Introduction Twenty to 30 percent of newly diagnosed bladder cancer cases are muscle- invasive (T2). Current National Comprehensive Cancer Network (NCCN) guidelines recommend radical cystectomy with consideration of neoadjuvant chemotherapy as the treatment for organ- confined T2 disease in selected patients. There are no formal recommendations of the timing of cystectomy after diagnosis of T2 disease. Nevertheless, there is general agreement that cystectomy should be performed within 12 weeks of diagnosis based on several studies that showed that delays of more than this period are associated with decreased disease- specific and overall survival as well as advanced pathological stage. (1,2) Greater than 20 to 30 percent of patients with T2 disease will die of their cancer after suffering metastases or local recurrence, with a five year survival of 66% after cystectomy. (3,4) Maine Medical Center (MMC) is a busy community / university- associated tertiary care and teaching institution with a multi- state referral base in the MaineHealth System. Maine Medical Partners Urology (MMPU) is the hospital s outpatient urology practice. Between 2004 and 2009, 25% of our surgery- eligible patients with muscle- invasive (T2) transitional cell carcinoma of the bladder who underwent cystectomy had a delay of greater than 90 days between diagnosis and cystectomy. To improve the flow of patients, ensuring that every patient with muscle- invasive bladder cancer makes a treatment decision and receives surgical treatment, if desired, within 90 days, we developed an analysis examining causes of delay of delivery of surgical treatment. A voluntary interdisciplinary team 2
3 identified possible barriers and points of intervention to reach this goal. The group prioritized barriers according to the impact, ease of implementation and projected efficacy of intervention. The main barriers included scheduling, patient choice factors, and comorbidity evaluation. We recently implemented several strategies / interventions at our practice to reduce the time from diagnosis to treatment to less than 90 days. This study evaluates our early experience with this approach. In this paper we describe a model to analyze and investigate the barriers that increase the time from diagnosis to the delivery of a surgical treatment modality. Ethical Issues The purpose of our improvement project was to improve the consistency of the time from diagnosis to cystectomy to achieve a time to surgery of less than 90 days. We did this through the process of ensuring that every patient with muscle- invasive bladder cancer makes a treatment decision and has surgery expecting them to have improved pathologic staging and cause- specific survival. Setting Maine Medical Center is a 637- bed hospital located in Portland, Maine. As a tertiary referral center, we see patients from all of Maine as well as parts of Vermont and New Hampshire. Urological services were provided initially by one private practice group composed of six urologists and radical cystectomy procedures were carried out in this facility by two of our urologists in the period. In 2009 the group became affiliated with Maine Medical Partners and MMC and is now composed of nine urologists. Three perform cystectomies, two of which are fellowship- trained oncologic surgeons. We perform approximately 20 to 30 cystectomies a year. A genitourinary cancer clinical nurse navigator facilitates the process of decision- making, treatment and recovery of patients by providing the appropriate resources and information to patients and physicians. The multidisciplinary team caring for our bladder cancer patients also includes a dedicated genitourinary medical oncologist providing comprehensive medical care. Planning and Intervention After reviewing performance from 2004 to 2009, 70 consecutive surgical candidate patients with T2 muscle- invasive transitional cell carcinoma of the bladder were identified. Thirty- four eligible patients had preoperative T2 muscle- invasive bladder cancer and did not receive neoadjuvant chemotherapy. Eight patients (24%) had delays greater than 90 days between diagnosis and cystectomy. Based on this, a quality improvement initiative was proposed to the practice- based clinical microsystems team and the group committed to achieving 100% compliance in having ct2 bladder cancer patients undergo cystectomy within 90 days of diagnosis. The Clinical Microsystems approach at Maine Medical Center is the model with which to assess inpatient and outpatient system efficiency and coordination 3
4 [5,6]. Several members of the urology practice had been trained in clinical microsystems tools through a medical center learning collaborative and the improvement tools were used by the group to redesign processes over the previous two years. A microsystems team was created composed of 11 members, including a urologist; a genitourinary cancer clinical nurse navigator; an oncology systems coordinator; an office visit scheduler; an office OR scheduler; an office manager; an office administrator; nurses from the OR, post anesthesia care and inpatient floor; and an administrator (urology program manager). Biweekly meetings were held to analyze the different factors that could potentially represent barriers which would be improved upon to achieve the less- than- 90- days time from diagnosis to surgery in our patients. The team analyzed the current process using brainstorming, multi- voting, process mapping and cause effect diagrams (Fishbone). Figure 1: Process Map for patients with invasive bladder cancer. 4
5 Figure 2: Fishbone diagram documenting barriers to appropriate treatment timing. Six problem categories were identified and 26 possible barriers and points of intervention were recognized. These barriers were prioritized by the group according to their impact, perceived ease of implementation of measures to counteract them and projected efficacy of intervention to overcome them. We approached all barriers at the same time, with different teams looking at each of the areas. The problem categories identified included the outside referral process to our practice, issues with the scheduling and with the actual post diagnosis first visit, issues with the ease of involvement of our nurse navigator, issues with events in the period between the recommendation to have surgery and the actual surgery (2 nd opinions, neoadjuvant chemotherapy) and issues with the surgery scheduling process. The main barriers (problems) were felt to be the ones regarding scheduling issues, patient choice factors, and comorbidity evaluation. The proposed quality improvement interventions to overcome these barriers were composed of five primary components: adjustment of OR scheduling; enhanced patient navigation; changes in the management of referrals; milestone alerts through the outpatient electronic medical record (EMR) for the patients providers; and modification of the scheduling process. 5
6 1. One of main components of our analysis was to assess and revise the operating room scheduling process to prevent scheduling delays. Cystectomies are lengthy procedures (4-6+ hrs) and therefore require extended OR times, and availability and presence of ancillary personnel familiar with the procedure. When limited access to the OR was recognized as a barrier to our process, data on the urologic utilization of the OR was obtained and a request was brought to the OR committee advocating for more OR time based on our improved survival data with bringing patients to surgery in less than 90 days after diagnosis. Another intervention was to move potential outpatient operations to our day surgery facility rather than the main inpatient hospital to maximize access to open surgery time at our main campus. 2. Although patient navigators have been in place in several clinical settings in our institution, they were underutilized for patients diagnosed with invasive bladder cancer. A preliminary review of medical charts revealed that a primary reason for delay for cystectomy, after the recommendation for surgery, was related to patient indecision or delay in moving through different treatment modalities. Thus we chose to more rigorously apply patient navigation to bladder cancer patients. This would systematize referral to the navigator and standardize patient education and navigation milestones to better assist patients in achieving informed decisions about their treatment in a timely fashion. Interventions included staff meetings to reinforce the need for referral and education of all our staff (including the physicians) about the role of our nurse navigator. The model for a patient navigator is to provide supplemental education about treatment risks, benefits and alternatives, and to assist the patient in navigating the individual steps from referral, second opinion, treatment and recovery. The nurse navigator would receive a referral upon diagnosis of T2 invasive bladder cancer and contact the patient by phone to review the treatment risks and benefits, answer any additional questions, and facilitate efficient decision- making. Facilitating efficient decision- making may be achieved through patient education alone, or by facilitating referrals for second opinions or contact with a patient who has undergone a similar treatment. The navigator would conduct periodic follow- up calls to ensure that the patient is progressing toward a final decision and initiation of treatment. Also, in the case of patients receiving a course of neoadjuvant therapy first, follow- up calls will be used to transition efficiently from chemotherapy to subsequent surgery. By involving our nurse navigator, and thus providing prompt and early education to our patients, our patients will come to a timely decision thereby reducing the interval from diagnosis to surgery. 3. Regarding our referral pattern issues, our interventions included revising our internal referral directly to a single scheduler (schedulers had jointly handled all urology scheduling previously) 6
7 paired to our nurse navigator to ensure all the pertinent information from outside referrals is available for our surgeon to evaluate. When information is incomplete, schedulers actively collect information prior to the scheduled visit. This new process required specialization of scheduling staff. 4. A new flow sheet was implemented through the outpatient electronic medical record (EPIC). The flow sheet appears as a single tab in the outpatient EMR and as milestones are reached, alerts are generated, so that the surgeon, navigator and schedulers are made aware of the time remaining before reaching the 90- day mark so that the appropriate scheduling procedures are undertaken as follows: as soon as a patient s TURBT indicates T2 invasive bladder cancer, an alert is sent to the patient navigator and to the surgeon s office prompting a visit with the surgeon to be scheduled. The next alert is sent to the patient navigator prompting patient contact once a treatment recommendation has been made; either for neoadjuvant therapy followed by cystectomy or for cystectomy directly. Finally, alerts to the patient navigator are generated at regular intervals from the date of treatment recommendation to ensure that patients finalize decisions in a timely manner. Regarding the electronic medical record per se, it will aid with the tracking of milestones from diagnosis to surgery, automatic referral, automatic reminders and reporting and enhancement of completeness of information. Maine Medical Center has implemented a single electronic medical record tool for all services system wide. Our chart review analysis revealed that another major cause of delay in receipt of treatment after recommendation for surgery related to the office and/or operating room scheduling and the coordination between the outpatient and inpatient systems. The flow sheet embedded in the EPIC EMR is used to a) combine and track data in a single location and b) generate alerts to the patient navigator, surgeon and hospital for patient tracking and efficient scheduling of treatment. 5. The scheduling process was altered to implement protected office block time for in- depth discussion about treatment options; a dedicated scheduler for oncology cases only; and protocol defined visits with nurse navigator, medical oncology, as well as early reservation of operating room time. The scheduler was also tasked with booking the patient s first post- diagnosis visit along with holding an OR block for potential cystectomy even prior to the patient decision. In selected patients, simultaneous appointment with medical oncology was booked to ensure prompt evaluation and possible implementation of neoadjuvant therapy if indicated. 7
8 Patients with bladder cancer are assigned to protected office blocks for cystectomy surgeons for their initial visits and follow up. As with our referral process, a primary oncology scheduler was assigned to our patients with bladder cancer, to centralize their flow through our system. Also, when a patient was identified to have muscle- invasive cancer, the patient would be assigned to his primary surgeon (if they did cystectomies) or to another cystectomy surgeon depending on the availability of a cystectomy surgeon s open OR time availability. Regarding the latter, the process would be facilitated by presentation of all our patients to our multidisciplinary tumor board to allow for transfer of care to an available cystectomy surgeon. Planning Study of the Intervention The specific aim of this project was to identify the factors delaying the time between diagnosis of muscle- invasive bladder cancer to cystectomy and implement interventions to achieve 100% of surgeries within 90 days of diagnosis. The primary outcome was the number of patients achieving surgery within 90 days of diagnosis, measured with real- time alerts in our EMR. To confirm ultimate compliance with the interventions, on a quarterly basis, the urology program manager and the oncology systems coordinator generate reports detailing T2 bladder cancer patients time from diagnosis to surgery. This will be an ongoing project with no defined end date. Impact to Date With all our planned interventions implemented by December 2010, patient flow was tracked and results indicate that all patients since have met the milestones towards meeting the 90- day window for surgical treatment. A system redesign to achieve 100% of the patients with T2 disease to undergo radical cystectomy within 90 days of diagnosis is feasible and achievable. (1 ) Gore, J. ; Lai, J. ; Setodji, C. ; et al. Mortality increases when radical cystectomy is delayed more than 12 weeks. Cancer, 2009; 115; (2) Sanchez- Ortiz, R.F. ; Huang, W.C. ; Mick, R. ; et al. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. Journal of Urology, 2003; 169: (3) Herr, H.; Dotan, Z.; Donat, S.; et al. Defining optimal therapy for muscle invasive bladder cancer. Journal of Urology, 2007:177: (4) Stein, J.P.; Lieskovsky, G.; Cote, R.; et al: Radical cystectomy in the treatment of invasive bladder cancer: long- term results in 1,054 patients. Journal of Clinical Oncology, 2001; 19(3):
9 (5) Nelson, E.C.; Godfrey, M.M.; Batalden, P.B.; et al: Clinical Microsystems, Part 1. The Building Blocks of Health Systems. The Joint Commission Journal on Quality and Patient Safety, 2008; 34(7): (6) Nelson, E.C.; Batalden, P.B.; and Godfrey, M.M. Quality By Design: A Clinical Microsystems Approach. San Francisco: John Wiley & Sons: Otto Sandoval, M.D. Urology Resident, Maine Medical Center 22 Bramhall Street, Portland, ME Andrew Blake Oncology Systems Coordinator, Maine Medical Center Cancer Institute 100 Campus Drive, Scarborough, ME Josh Barnes- Livermore Urology Program Manager Maine Medical Center Doug Salvador, M.D., MPH Vice President, Quality and Patient Safety, Maine Medical Center Assistant Professor of Medicine, Tufts University School of Medicine Brian Jumper, M.D. Director of Pediatric Urology, Maine Medical Partners Urology Assistant Clinical Professor, Tufts University School of Medicine 100 Brickhill Avenue, South Portland, ME Jennifer Powers Oncology Nurse Navigator Maine Medical Center Cancer Institute Moritz Hansen, M.D. Co- Director, Division of Urology, Maine Medical Partners Urology Assistant Clinical Professor, Tufts University School of Medicine Craig Hawkins, M.D. Maine Medical Partners Urology, Assistant Clinical Professor 9
Monitoring non compliant diabetic A1C levels
The University of San Francisco USF Scholarship: a digital repository @ Gleeson Library Geschke Center Master's Projects and Capstones Theses, Dissertations, Capstones and Projects Summer 8-17-2015 Monitoring
More informationLara Kujtan, MD; Abdulraheem Qasem, MD
The Treatment of Lung Cancer Between 2013-2014 at Truman Medical Center: A Retrospective Review in Fulfillment of the Requirements of Standard 4.6 (Monitoring Compliance with Evidence- Based Guidelines)
More informationACGME Clinical Fellowship Program: Micrographic Surgery and Dermatologic Oncology Fellowship. Program Demographics
ACGME Clinical Fellowship Program: Micrographic Surgery and Dermatologic Oncology Fellowship Program Demographics 1. Name of Host Institution: University of California San Francisco 2. Program: Dermatology
More informationA06/S(HSS)b Ex-vivo partial nephrectomy service (Adult)
A06/S(HSS)b 2013/14 NHS STANDARD CONTRACT FOR EX-VIVO PARTIAL NEPHRECTOMY SERVICE (ADULT) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATION Service Specification No. Service Commissioner
More informationNeoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
Neoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Andrew J. Stephenson, MD, FRCSC, FACS Director, Urologic Oncology Associate Professor of Surgery Glickman Urological and Kidney
More informationBukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania
Bukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania COUNTRY: Tanzania Tanzania has successfully implemented the standard
More informationEnhancing Quality of Life for Cancer Survivors in South Dakota. Outcomes from the South Dakota Cancer Survivorship Program
Enhancing Quality of Life for Cancer Survivors in South Dakota Outcomes from the South Dakota Cancer Survivorship Program The South Dakota Survivorship Program was funded through cooperative agreement
More informationHepatobiliary Malignancies Retrospective Study at Truman Medical Center
Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which
More informationFigure 1. Survivorship Program Model
Implementation of a Breast Cancer Survivorship Program Heather Lowry MSN, WHNP-BC, Nayana Dekhne MD, Ryan Wood, BCSc-IE, MBA, CSSBB, Angela DeLaere, MBA Beaumont Health, Royal Oak, MI Background As of
More informationTable 1 Standards and items to set up a PCU: general requirements and critical mass
Table 1 Standards and items to set up a PCU: general requirements and critical mass General requirements and European Prostate Cancer Units are structures managing sufficient volumes of patients with on-site
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) - 2011/12 Dr Angela Morgan
More informationTotal Number Programs Evaluated: 382 January 1, 2000 through October 31, 2017
Page 1 Oral and Maxillofacial Surgery -Residency INFORMATIONAL REPORT ON FREQUENCY OF CITINGS OF ACCREDITATION STANDARDS FOR ADVANCED SPECIALTY EDUCATION PROGRAMS IN ORAL AND MAXILLOFACIAL SURGERY Frequency
More information2009 Annual Report Alvin & Lois Lapidus Cancer Institute LifeBridge Health
2009 Annual Report Alvin & Lois Lapidus Cancer Institute LifeBridge Health Dear Collegues, The Alvin and Lois Lapidus Cancer Center is proud of its reputation as a Cancer Center that has gained community,
More information9/30/2016. Chris E. Freise, MD Professor of Surgery UCSF Transplant Division
Chris E. Freise, MD Professor of Surgery UCSF Transplant Division Clear advantages over deceased donation for kidney transplant Shorter wait times Better short and long term function Improved graft half-life
More informationLymph node dissection: how much is enough?
1 Background Lymph node dissection: how much is enough? Eila C. Skinner, MD Professor of Clinical Urology USC Keck School of Medicine Radical cystectomy is the gold standard for the treatment of invasive
More informationThe Center for Cancer Prevention and Treatment Public Reporting of Outcomes
The Center for Cancer Prevention and Treatment 2017 Public Reporting of Outcomes Cancer Screening Program - CoC Standard 4.2 Oral Cancer Screening Event Identified Community Need According to the 2014
More informationIntegrated Health Care Services
Integrated Health Care Services Integrated Health Care Services Programs with integrated health care services achieve the strongest results. Strategies for creating integrated care systems include: Educating
More informationMeasure the Quality of Robot-Assisted Surgery
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationTHE NEUROSCIENCE INSTITUTE OF NEW YORK HOSPITAL QUEENS
THE NEUROSCIENCE INSTITUTE OF NEW YORK HOSPITAL QUEENS PROVIDING A HIGHER LEVEL OF COMPREHENSIVE CARE OF THE BRAIN AND NERVOUS SYSTEM. RIGHT HERE. IN QUEENS. The Neuroscience Institute is The Center for
More informationVeterans and Bladder Cancer webinar. Part I: Medical Overview
Veterans and Bladder Cancer webinar Tuesday March 1, 2016 Part I: Medical Overview Presented by Dr. Jennifer Taylor is an assistant professor of urology at the University of Pittsburgh School of Medicine.
More informationAdaptation of Survivorship Care Plans in the Age of the EMR Challenges & Practical Solutions
Adaptation of Survivorship Care Plans in the Age of the EMR Challenges & Practical Solutions Elizabeth McGrath, DNP, APRN Darcy Kreis MS, RN Norris Cotton Cancer Center Dartmouth Hitchcock Medical Center
More informationMaria Parham Cancer Center Henderson NC Annual Report 2013
Maria Parham Cancer Center Henderson NC Annual Report 2013 2013 has been a vibrant year of change for the Maria Parham Cancer Center, changes aimed at improving the quality of patient care as well as patient
More informationPush Partner Registry Guide A healthcare provider s guide to provider-based distribution of pandemic influenza vaccine in Kent County
Push Partner Registry Guide A healthcare provider s guide to provider-based distribution of pandemic influenza vaccine in Kent County A Supplement to the Kent County Health Department Pandemic Influenza
More informationResearch Article Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions
Advances in Urology Volume 14, Article ID 746298, 6 pages http://dx.doi.org/1.1155/14/746298 Research Article Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions N.
More informationPeer Support Services Improve Clinical Outcomes by Fostering Recovery and Promoting Empowerment
Peer Support Services Improve Clinical Outcomes by Fostering Recovery and Promoting Empowerment Optum has recognized the role of peer support services as an integral part of state Medicaid plans and has
More information2012 Annual Report on Childhood Lead Poisoning Prevention
Report to The Vermont Legislature 2012 Annual Report on In Accordance with 18 V.S.A. 1756 Submitted to: Submitted by: Prepared by: General Assembly Harry Chen, M.D., Commissioner Vermont Department of
More informationAsthma: Evaluate and Improve Your Practice
Potential Barriers and Suggested Ideas for Change Key Activity: Initial assessment and management Rationale: The history and physical examination obtained from the patient and family interviews form the
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician ASWCN TAUNTON AND SOMERSET Taunton Lung MDT (11-2C-1) - 2011/12 Dr Sarah Foster Compliance Self Assessment LUNG MDT
More informationFondazione IRCCS Istituto Nazionale dei Tumori
Fondazione IRCCS Istituto Nazionale dei Tumori General info Unit Director: Riccardo Valdagni, Radiation Oncology 1 and Prostate Cancer Program Interdisciplinary and Multiprofessional Team Core Team Urologists,
More informationPhillip Schnell, Resident at The New Jewish Home ENGAGING RESIDENTS & EXPANDING THERAPY TO ACHIEVE A REDUCTION IN READMISSION
Phillip Schnell, Resident at The New Jewish Home ENGAGING RESIDENTS & EXPANDING THERAPY TO ACHIEVE A REDUCTION IN READMISSION ABOUT THE PROJECT ABOUT THE NEW JEWISH HOME With more than 160 years of experience
More informationABA. The American Board of Anesthesiology. Media Kit
ABA The American Board of Anesthesiology Media Kit ABOUT THE ABA The American Board of Anesthesiology (ABA) is a nonprofit organization whose mission is to advance the highest standards of the practice
More informationCommunity Health Improvement Plan
Community Health Improvement Plan Methodist University Hospital Methodist Le Bonheur Healthcare (MLH) is an integrated, not-for-profit healthcare delivery system based in Memphis, Tennessee, with 1,650
More informationRequest for Proposals (RFP) for School-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Services
Request for Proposals (RFP) for School-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Services As issued by Montgomery County Alcohol, Drug Addiction and Mental Health Services
More informationFixing footcare in Sheffield: Improving the pathway
FOOTCARE CASE STUDY 1: FEBRUARY 2015 Fixing footcare in Sheffield: Improving the pathway SUMMARY The Sheffield Teaching Hospitals NHS Foundation Trust diabetes team transformed local footcare services
More information2017 CANCER COMMITTEE ANNUAL REPORT
2017 CANCER COMMITTEE ANNUAL REPORT steliz.org Chairman s Message The Cancer Committee at HSHS St. Elizabeth s Hospital had diligently worked to improve the care and outcomes of cancer patients throughout
More information(C) GoldCal LLC DBA GoldSRD
ROOT CAUSE ANALYSIS Danny M. Goldberg, Founder Root Cause Analysis Problem or Unwanted Event Occurrence Symptoms Problem or Unwanted Event Recurrence Apparent Cause Root Cause Prevent Wilson, Dell, and
More informationGuideline for the Management of Patients Suitable for Immediate Breast Reconstruction
Version History Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction Version Summary of change Date Issued 2.0 Endorsed by the Governance Committee 20.02.08 2.1 Circulated
More informationGuideline for Fertility Preservation for Patients with Cancer
Guideline for Fertility Preservation for Patients with Cancer COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For Informational Purposes
More informationWhen to Integrate Surgery for Metatstatic Urothelial Cancers
When to Integrate Surgery for Metatstatic Urothelial Cancers Wade J. Sexton, M.D. Senior Member and Professor Department of Genitourinary Oncology Moffitt Cancer Center Case Presentation #1 67 yo male
More informationCommunity Health Improvement Plan. Annual Health Preliminary Status Update 2014 Year Year 2
Community Health Improvement Plan 2014-2016 Annual Health Preliminary Status Update 2014 Year 1 2015 Year 2 To Our Community Members: Although the healthcare landscape is always changing, one constant
More informationImplementation of Hematology- Oncology Education Program. Amir Steinberg, MD Samuel Oschin Comprehensive Cancer Center Cedars-Sinai Medical Center
Implementation of Hematology- Oncology Education Program Amir Steinberg, MD Samuel Oschin Comprehensive Cancer Center Cedars-Sinai Medical Center Cedars-Sinai Medical Center Large, tertiary care center
More informationKadlec Regional Medical Center Cancer Committee November 10 th, 2016
Kadlec Regional Medical Center Cancer Committee November 10 th, 2016 Public Reporting of Outcomes As part of Kadlec Regional Medical Center s mission to provide quality health care for every patient, the
More informationReach Out to Patients for Better Disease Management
CASE STUDY Reach Out to Patients for Better Disease Management Logansport Memorial Hospital How automated reminders led to a higher compliance rate for overdue labs by diabetic patients. Quick Summary
More informationOCTOBER EOEA and the Alzheimer s Association have organized implementation of the plan around its five major recommendations:
1 MASSACHUSETTS ALZHEIMER S DISEASE AND RELATED DISORDERS STATE PLAN RECOMMENDATIONS TWO-YEAR PROGRESS REPORT OCTOBER 2014 In February 2012, Massachusetts released a set of Alzheimer s Disease and Related
More informationNewYork-Presbyterian Hospital Weill Cornell Medical Center Division of Dentistry, General Dentistry Program Goals and Objectives
Program Overview NewYork-Presbyterian Hospital Weill Cornell Medical Center Division of Dentistry, General Dentistry Program Goals and Objectives The program is one year in length with one position as
More informationThe Current Landscape of Nurse Navigators: Oncology and the Impact on Outcomes
The Current Landscape of Nurse Navigators: Oncology and the Impact on Outcomes SHERYL RILEY RN, OCN, CMCN DIRECTOR OF CLINICAL SERVICES SAI SYSTEMS SRILEY@SAISYSTEMS.COM 2015 SAI SYSTEMS INTERNATIONAL
More informationPEDIATRIC OTOLARYNGOLOGY FELLOWSHIP. B.C. Children s Hospital University of British Columbia Vancouver, B.C.
PEDIATRIC OTOLARYNGOLOGY FELLOWSHIP B.C. Children s Hospital University of British Columbia Vancouver, B.C. Program Director: Number of Positions: Dr. Neil K Chadha One per annum Next available Fellowship
More informationSafeguarding Annual Report
Safeguarding Annual Report 2016-17 Antony Heselton Head of Safeguarding and Prevent Lead 2016-2017 June 2017 1 Contents 1. Executive Summary. 3&4 2. Standards. 4&5 3. Action Plan Review. 5 4. Activity.
More informationBladder Preservation Protocols in the Treatment of Muscle-Invasive Bladder Cancer
Bladder-preserving therapy is a safe and effective alternative to cystectomy for carefully selected patients with bladder cancer. Michael Mahany. Trumpeter Swans on Byer s Lake. Photograph. Denali National
More informationRHODE ISLAND CANCER PREVENTION AND CONTROL
RHODE ISLAND CANCER PREVENTION AND CONTROL 2013 2018 STRATEGIC PLAN TABLE OF CONTENTS Purpose 1 The Partnership to Reduce Cancer 3 Prevention 4 Tobacco 4 Healthy Weight 6 Nutrition 6 Physical Activity
More information2016 Oncology Institute Annual Report
2016 Oncology Institute Annual Report Message from the Cancer Committee: On behalf of the Cancer Committee of The Methodist Hospitals, we are pleased to present to you our 2016 Oncology Institute Annual
More informationNCI Community Cancer Centers Program
NCI Community Cancer Centers Program BIOSPECIMENS SURVIVORSHIP Andrew L. Salner, MD FACR Director, Helen & Harry Gray Cancer Center Hartford Hospital Hartford, CT Hartford Hospital 865 bed community and
More informationGenitourinary Oncology Fellowship for Physicians in China A Multidisciplinary Clinical and Research Training Opportunity at Massachusetts General
Genitourinary Oncology Fellowship for Physicians in China A Multidisciplinary Clinical and Research Training Opportunity at Massachusetts General Hospital Cancer Center 2 Genitourinary Oncology Fellowship
More informationCliniques universitaires Saint Luc
Cliniques universitaires Saint Luc General info Unit Director: Bertrand TOMBAL, Urology Interdisciplinary and Multiprofessional Team Core Team Urologists, Radiation Oncologists, Medical Oncologists, Pathologists,
More informationREPORT. A Model Clinical Trials System for the 21st Century
www.georgiacore.org www.georgiacancertrials.org REPORT A Model Clinical Trials System for the 21st Century A Response to the Institute of Medicine s 2010 Report A National Cancer Clinical Trials System
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT NECN N Tees & Hartlepool North Tees And Hartlepool Date Self Assessment Completed 23rd July 2009 Date of IV Review 19th June 2009
More informationAttachment #2 Overview of Follow-up
Attachment #2 Overview of Follow-up Provided below is a general overview of follow-up and this may vary based on specific patient or cancer characteristics. Of note, Labs and imaging can be performed closer
More informationPEDIATRIC OTOLARYNGOLOGY-HEAD AND NECK SURGERY CLINICAL FELLOWSHIP. B.C. Children s Hospital University of British Columbia Vancouver, B.C.
PEDIATRIC OTOLARYNGOLOGY-HEAD AND NECK SURGERY CLINICAL FELLOWSHIP B.C. Children s Hospital University of British Columbia Vancouver, B.C. Program Director: Number of Positions: Dr. Neil K Chadha One per
More informationImproving services for upper GI (OG) cancer Application template (Version 2)
Trust Clinical lead Improving services for upper GI (OG) cancer Application template (Version 2) Managerial lead Date completed 14 June 2013 Barnet & Chase Farm Hospitals NHS Trust Dr Marta Carpani Upper
More informationCancer Registrars: Beyond the Abstract
Cancer Registrars: Beyond the Abstract Presented by Melissa Smith, RHIT, CTR Director of Client Services CHAMPS Oncology Objectives Identify what is a Certified Tumor Registrar (CTR) and how someone becomes
More informationAppendix C NEWBORN HEARING SCREENING PROJECT
Appendix C NEWBORN HEARING SCREENING PROJECT I. WEST VIRGINIA STATE LAW All newborns born in the State of West Virginia must be screened for hearing impairment as required in WV Code 16-22A and 16-1-7,
More informationOptimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital
Optimized propels high utilization of PET/MR at Pitié-Salpêtrière Hospital clinical pathway As one of Europe s largest teaching hospitals, Pitié-Salpêtrière Hospital is renowned for its innovative research
More informationThe European Board of Urology
Page 1 of 15 The European Board of Urology Sub-specialty certification application: Prostate cancer, A - General information A1 - APPLICATION IDENTIFICATION 1a. Application code blank 1b. EBU internal
More informationRetrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer.
Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer. Goal of the study: 1.To assess whether patients at Truman
More informationPROSTATE CANCER: Meeting a Community Need
outcomes REPORT 2017 PROSTATE CANCER: Meeting a Community Need 1 in 6 men will be diagnosed with prostate cancer in their lifetime. 1 southnassau.org/cancer outcomes REPORT 2017 Within the primary service
More informationSeptember 10, Dear Dr. Clark,
September 10, 2015 Peter E. Clark, MD Chair, NCCN Bladder Cancer Guidelines (Version 2.2015) Associate Professor of Urologic Surgery Vanderbilt Ingram Cancer Center Nashville, TN 37232 Dear Dr. Clark,
More informationImproving Cancer Pathways. Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust
Improving Cancer Pathways Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust Background Poor / inconsistent 62 day performance, across a number of specialities
More informationSparrow Cancer Center Updated Naming Opportunities
Sparrow Cancer Center Updated Naming Opportunities $5,000,000 Sparrow Plaza Building This new four-story building, located centrally on the Sparrow Campus, will create a home for an expanded Cancer Center
More informationVolume 14, Issue 4, Oncology special
Volume 14, Issue 4, 2012 - Oncology special The growing role of interventional oncology within multidisciplinary cancer care Interventional radiology (IR) is already well established within the field of
More informationDouglas County s Mental Health Diversion Program
Douglas County s Mental Health Diversion Program Cynthia A. Boganowski The incarceration of people with serious mental illness is of growing interest and concern nationally. Because jails and prisons are
More information2016 Cancer Program Outcomes Report
2016 Cancer Program Outcomes Report 1 2016 Community Outreach Report Cancer Program Accreditation by The Commission on Cancer Central Florida Health Cancer Program was accredited by the Commission on Cancer
More informationUrology Case Conference (a.k.a. Pyelogram, IVP) Time/Location: 2nd Monday of every month at 07:00 08:30
Conferences The AUA curriculum for residency training (http://www.auanet.org/eforms/elearning/core/index.cfm) has been adopted as the official guide for training at our institution. Didactic conferences
More informationMusculoskeletal Tumor Society Curriculum Guidelines for Clinical Fellowship Programs In Musculoskeletal Oncology
Musculoskeletal Tumor Society Curriculum Guidelines for Clinical Fellowship Programs In Musculoskeletal Oncology Preamble: The Musculoskeletal Tumor Society (MSTS) is committed to excellence in the fellowship
More informationAll four components must be present, but Part A funds to be used for HIV testing only as necessary to supplement, not supplant, existing funding.
EARLY INTERVENTION SERVICES I. DEFINITION OF SERVICE Support of Early Intervention Services (EIS) that include identification of individuals at points of entry and access to services and provision of:
More informationFlu Vaccination Clinics
Flu Vaccination Clinics June 18, 2009 Shepell fgi Contact: Paula Allen Vice President Organizational Solutions & Training 416-355-5495 1-800-461-9722 ext. 5495 pallen@shepellfgi.com www.shepellfgi.com
More informationDecipher Bladder Predicts Which Patients May Benefit from Neoadjuvant Chemotherapy Prior to Radical Cystectomy
Decipher Bladder Predicts Which Patients May Benefit from Neoadjuvant Chemotherapy Prior to Cystectomy Contact the GenomeDx Customer Support Team 1.888.792.1601 (toll-free) customersupport@genomedx.com
More informationFertility Center and Sperm Bank Manual for the Fertile Hope Program for Men
Fertility Center and Sperm Bank Manual for the Fertile Hope Program for Men Table of Contents I. Fertile Hope Program for Men: An Overview...3 II. Referring to the Fertile Hope Program in Your Publications.3
More informationCentre for Research on Ageing [influencing policy improving practice enhancing quality of life]
Centre for Research on Ageing [influencing policy improving practice enhancing quality of life] Associate Professor Barbara Horner (PhD) Director, Centre for Research on Ageing, Faculty of Health Sciences.
More informationLung cancer timed clinical pathways
Lung cancer timed clinical pathways December 2017 1 Context This document sets out best practice timed clinical pathways for lung cancer. It is anticipated that all Cancer Alliances will audit against
More informationPedram Bral, M.D. Maimonides Medical Center Brooklyn, New York
Pedram Bral, M.D. Maimonides Medical Center Brooklyn, New York 2-Year Program Optional Degrees: MPH MBA MS Other: None Number of Faculty: GYN Faculty: 4 UROGYN Faculty: 2 REI Faculty: 1 ONCOLOGY Faculty:
More informationParticipants in the Program
Type 2 Diabetes Performance Improvement Initiative: Chart Reviews Participants in the Program 318 clinicians have registered 192 have started the program 126 have started their initial chart review 26
More informationMinistry of Children and Youth Services. Follow-up to VFM Section 3.01, 2013 Annual Report RECOMMENDATION STATUS OVERVIEW
Chapter 4 Section 4.01 Ministry of Children and Youth Services Autism Services and Supports for Children Follow-up to VFM Section 3.01, 2013 Annual Report RECOMMENDATION STATUS OVERVIEW # of Status of
More informationASCO s Quality Training Program
ASCO s Quality Training Program Project Title: Improving Time to Initiation of Bone Modifying Agents in Patients with Newly Diagnosed Multiple Myeloma Presenters: Sarah Lee, MD and Nathaniel Rosko, PharmD,
More information/12. mmc.org
141754 2/12 www.mmc.org mmc.org OUR MISSION Maine Medical Center (MMC) is dedicated to maintaining and improving the health of the communities it serves by: Caring for our community Educating tomorrow
More informationMLC-2 IN KANSAS MCH Oral Health Screening Quality Improvement Project
Pottawatomie Riley Geary MLC-2 IN KANSAS MCH Oral Health Screening Quality Improvement Project (Storyboard: May 2007 February 2008) Wildcat Public Health Region Number of Assessments Table of Contents
More informationGood News Santa Monica!
Children s Hospital Los Angeles Santa Monica is located in the Saint John s Medical Plaza, one block northeast of St. John s Health Center. 1301 20th St., Ste. 460, Santa Monica, CA 90404 Appointments:
More informationMEDitorial March Bladder Cancer
MEDitorial March 2010 Bladder Cancer Last month, my article addressed the issue of blood in the urine ( hematuria ). A concerning cause of hematuria is bladder cancer, a variably malignant tumor starting
More informationOverview...3. Cancer Program.4. Breast Cancer with 5-year Survival Analysis...6. Systemic Therapy.7. Stage of Breast Cancer Diagnosed in
2011 Annual Report Table Of Contents Overview...3 Cancer Program.4 Breast Cancer with 5-year Survival Analysis...6 Systemic.7 Stage of Breast Cancer Diagnosed in 2008..8 Radiation and Systemic Only...9
More informationCancer Improvement Plan Update. September 2014
Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update
More informationPlugging the Dike: Capturing and Reporting Clinical Test Results: An Enterprise Risk Management Approach
Plugging the Dike: Capturing and Reporting Clinical Test Results: An Enterprise Risk Management Approach Susan Penney, JD Director of Risk Management UCSF Medical Center June 14, 2012 Overview What is
More information28 OI November December A Medical Home for Adolescents and Young Adults with Cancer
28 OI November December 2013 www.accc-cancer.org A Medical Home for Adolescents and Young Adults with Cancer By Douglas S. Hawkins, MD Our team consists of more than 30 doctors specializing in cancers
More informationASST Papa Giovanni XXIII
ASST Papa Giovanni XXIII General info Unit Director: Marco Roscigno, Interdisciplinary and Multiprofessional Team Core Team Urologists, Radiation Oncologists, Medical Oncologists, Pathologists, Data Managers
More informationRoutinizing HIV and HCV Testing Using an Innovative, Scalable and Sustainable Dual Testing Model
Routinizing HIV and HCV Testing Using an Innovative, Scalable and Sustainable Dual Testing Model Catelyn Coyle MPH, MEd Public Health National Symposium June 2014 Outline Background Description of model
More informationHofstra Northwell School of Medicine Department of Neurology Epilepsy Fellowship Program. Skills and Competencies Rotation Goals and Objectives
Hofstra Northwell School of Medicine Department of Neurology Epilepsy Fellowship Program Skills and Competencies Rotation Goals and Objectives The purpose of the Epilepsy fellowship program is to provide
More informationGood News Encino! California s Best health care for kids is right in your backyard.
Good News Encino! California s Best health care for kids is right in your backyard. Children s Hospital Los Angeles Founded in 1901, Children s Hospital Los Angeles is one of the nation s leading children
More informationCollaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home
Collaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home Background Safety net facility serving the community for more than 140 years Employ over 3500 health
More informationResearch Article Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience
International Scholarly Research Notices, Article ID 702653, 6 pages http://dx.doi.org/10.1155/2014/702653 Research Article Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer
More informationGood Samaritan Oncology Services. Vincennes, Indiana
Good Samaritan Oncology Services Vincennes, Indiana } Classified as a Community Cancer Center by CoC >100 and < 500 newly diagnosed cases each year Provide a full range of diagnostic and treatment services.
More informationGUIDELINES OF THE SACFNA PUBLIC RELATIONS TASK GROUP OF NARCOTICS ANONYMOUS
GUIDELINES OF THE SACFNA PUBLIC RELATIONS TASK GROUP OF NARCOTICS ANONYMOUS In keeping with the spiritual nature of Narcotics Anonymous, our structure should always be one of service, never of government.
More informationMERCY UC DAVIS CANCER CENTER NEWSLETTER. Cancer Center News 2017 ANNUAL REPORT
MERCY UC DAVIS CANCER CENTER NEWSLETTER Cancer Center News 2017 ANNUAL REPORT In this issue 02 Letter from the Director 03 Quality Improvement 05 Nursing 06 Cancer Center Supportive Services 07 Programmatic
More information